Director, Phase I Clinical Trials Unit

University of Alabama at Birmingham School of Medicine
Birmingham, Alabama
Feb 01, 2019
Mar 03, 2019
Hematology, Oncology
Full Time
Position Type

Search for Director, Phase I Clinical Trials Unit

Division of Hematology and Oncology

Comprehensive Cancer Center

University of Alabama at Birmingham School of Medicine


The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB) and Division of Hematology and Oncology, Department of Medicine seek a distinguished clinician/scientist to serve as the next Director of the Phase I Clinical Trials Unit. Reporting to the Director of the O’Neal Comprehensive Cancer Center and the Division of Hematology and Oncology Director, appropriate candidates will also serve as the Albert F. LoBuglio Endowed Chair in Translational Research. The next Director will have a tremendous opportunity to lead the only dedicated Phase I program in the state of Alabama during at time of strategic growth at UAB.

The O’Neal Comprehensive Cancer Center (CCC) is a premier research entity, one of only two NCI-designated comprehensive cancer centers in the Deep South, and the only one in a three-state area that includes Alabama, Mississippi, and Louisiana. The O’Neal CCC is especially regarded for its expertise in translational research. The Cancer Center currently offers patients access to more than 200 clinical trials, some of which feature drugs and therapies discovered at UAB and that are not available elsewhere. The distinctive Phase I program, established in 2015, enhances the University’s ability to conduct Phase I studies through a patient-centered approach in which a dedicated team is responsible for conducting first-in-human clinical trials.

The O’Neal CCC and UAB seeks an exceptional oncologist and leader with a track-record of Phase I research activity to catalyze the research of a world-class team of scientists in Phase I clinical trials. With a robust infrastructure in place to support clinical trials, the Director will be charged with developing a strategic vision for continued expansion of the unit, which currently supports more than 40 active trials with 30 staff. The Director will be a critical partner to leadership in the Division of Hematology and Oncology and the Cancer Center to promote a culture of transformative research and collaboration across all of UAB Medicine. The O’Neal CCC is poised for continued growth of protocols and patient participation.

Isaacson, Miller is assisting with this search. Inquiries, nominations, and applications will be treated confidentially. Interested applicants are invited to submit their curriculum vitae and letter of interest including a statement of qualifications to:

Ariannah Mirick, Partner

Katherine Stellato, Senior Associate

Isaacson, Miller

263 Summer Street

Boston, MA 02210

Electronic submission of materials is strongly preferred.

UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work-life balance irrespective of, race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans. A pre-employment background check investigation is performed on candidates selected for employment.

Physicians and other clinical faculty candidates who will be employed by the University of Alabama Health Services Foundation (UAHSF) or other UAB Medicine entities, must successfully complete a pre-employment drug and nicotine screen to be hired.